AYOLLAR MASLAHATXONASI MUASSASASINING REPRODUKTIV YOSHDAGI AYOLLAR ORASIDA GINEKOLOGIK KASALLIKLARNI OLDINI OLISHDAGI O‘RNI

##plugins.themes.bootstrap3.article.sidebar##

PDF
Nashr: Jild 6 Nomeri 2 : Eurasian Journal of Academic Research
Bo'lim: Maqolalar
##semicolon##
##submission.license.cc.by4.footer##

##plugins.themes.bootstrap3.article.main##

2-son Jamoat salomatligi va sog'liqni saqlashni boshqarish kafedrasi Toshkent davlat tibbiyot universiteti, O'zbekiston
info@in-academy.uz

Abstrak:

Ginekologik kasalliklar reproduktiv yoshdagi ayollar orasida jiddiy sog'liqni saqlash muammosi bo'lib qolmoqda va kasallanish, hayot sifatining pasayishi va reproduktiv tizimning salbiy natijalariga katta hissa qo'shadi. Profilaktik tibbiy yordam xizmatlari ginekologik kasalliklarni erta aniqlash, xavfni kamaytirish va o'z vaqtida davolashda muhim rol o'ynaydi. Ayollar maslahat klinikalari birlamchi tibbiy yordam tizimlarining asosiy tarkibiy qismi bo'lib, reproduktiv salomatlik xizmatlari, profilaktik tekshiruvlar, sog'liqni saqlash bo'yicha ta'lim va maslahatlarni taqdim etadi. Ushbu tadqiqot reproduktiv yoshdagi ayollar orasida ginekologik kasalliklarning oldini olishda ayollar maslahat klinikalarining roli va samaradorligini baholashga qaratilgan. Profilaktik strategiyalarga, jumladan, muntazam ginekologik tekshiruvlar, skrining dasturlari, sog'liqni saqlash bo'yicha ta'lim va erta tashxis qo'yishga alohida e'tibor qaratiladi

##semicolon##

##plugins.themes.bootstrap3.article.details##

##submission.howToCite##:

Voitova, G. (2026). AYOLLAR MASLAHATXONASI MUASSASASINING REPRODUKTIV YOSHDAGI AYOLLAR ORASIDA GINEKOLOGIK KASALLIKLARNI OLDINI OLISHDAGI O‘RNI. Yevrosiyo Ilmiy Tadqiqotlar Jurnali, 6(2), 84–90. Retrieved from https://in-academy.uz/index.php/ejar/article/view/74248

##submission.citations##:

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

European Commission. (2015). European guidelines for quality assurance in cervical cancer screening (2nd ed.). Office for Official Publications of the European Union.

Kassebaum, N. J., Arora, M., Barber, R. M., Brown, J., Carter, A., Casey, D. C., … Vos, T. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015. The Lancet, 388(10053), 1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6

Lönnberg, S., Anttila, A., Luostarinen, T., & Nieminen, P. (2013). Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiology, Biomarkers & Prevention, 22(8), 1354–1361. https://doi.org/10.1158/1055-9965.EPI-13-0165

Moyer, V. A. (2012). Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 156(12), 880–891. https://doi.org/10.7326/0003-4819-156-12-201206190-00424

Oh, J. K., Weiderpass, E., & Franceschi, S. (2014). Epidemiology of vulvar and vaginal cancers. Best Practice & Research Clinical Obstetrics & Gynaecology, 28(1), 77–87. https://doi.org/10.1016/j.bpobgyn.2013.08.003

World Health Organization. (2016). WHO guidelines for the treatment of Chlamydia trachomatis. World Health Organization.

World Health Organization. (2022). Consolidated guideline on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care. World Health Organization.

World Health Organization. (2023). Global strategy for cervical cancer elimination. World Health Organization.